Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Sampling Human
AddedFeb 16, 2024
UpdatedJun 18, 2026
Sampling Human

Sampling Human

Seed

Sampling Human: Advancing health tech by linking decisions to cellular effects for precise diagnoses.

HQ
Berkeley, CA, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Sampling Human is a health-focused technology provider on a mission to integrate single-cell precision into everyday life. The company aims to revolutionize clinical diagnosis by linking health-related decisions to their effects at the cellular level. Their approach addresses the complexity of the human body, which comprises trillions of cells, each influencing overall health in unique ways.

The company's innovative technology seeks to overcome the limitations of current cell evaluation methods, which are often inefficient and provide limited information. By developing more comprehensive and precise cellular analysis techniques, Sampling Human strives to improve diagnostic accuracy, potentially reducing delays in identifying rare diseases and minimizing misdiagnoses. This advancement could significantly impact patient outcomes and transform the field of medical diagnostics.

Sampling Human - Similar Companies

Deepcell logo

Deepcell

EarlyCell logo

EarlyCell

Celldom logo

Celldom

celldom.com

Cellarity logo

Cellarity

Cellia Science logo

Cellia Science

celliasci.com

Celula logo

Celula

RareCyte logo

RareCyte

rarecyte.com

The Sampling Solutions logo

The Sampling Solutions

ExPrimary logo

ExPrimary

exprimary.com

Sapphiros logo

Sapphiros

sapphiros.com

HI-Bio logo

HI-Bio

hibio.com

Scribe Biosciences logo

Scribe Biosciences

Nanopath logo

Nanopath

nanopathdx.com

Cellara logo

Cellara

Aperture Bio logo

Aperture Bio

aperture.bio

Sampling Human - Quick Facts

Who are Sampling Human's competitors?

Companies similar to Sampling Human include Deepcell, EarlyCell, Celldom and Cellarity.

When was Sampling Human founded?

Sampling Human was founded in 2016.

Where is Sampling Human's headquarters located?

Sampling Human's headquarters is located in Berkeley, CA, US.

When was Sampling Human's last funding round?

Sampling Human's most recent funding round was for $2M (USD) in April 2022.

How much has Sampling Human raised to-date?

As of Apr 12, 2022, Sampling Human has raised a total of $3.7M (USD).

How many employees does Sampling Human have?

Sampling Human has 37 employees as of Feb 4, 2024.

Sampling Human - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • HealthTech
Tags
  • Data Information
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software